Chinese government-linked hackers targeted U.S.-based coronavirus vaccine research developer Moderna Inc. in a bid to steal data, according to a U.S. security official tracking Chinese hacking.
If you are not happy with the results below please do another search
50 search results for:
Results of a pivotal phase III study of Supernus Pharmaceuticals’ SPN-812 (viloxazine extended-release capsules) were published in the journal Clinical Therapeutics.
Med Ad News spoke with Jennifer Brekke, principal and CEO of SCOUT Health, and Michael Treff, president of Code and Theory, about the formation of Code and Theory Health, a new business unit of the two agencies specifically focused on healthcare.
AbbVie’s investigational migraine drug atogepant significantly reduced mean monthly migraine days across a 12-week course of treatment.
Boehringer Ingelheim and Eli Lilly announced that the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, met the primary endpoint.
Genentech is eliminating 474 employees, mostly based out of the company’s South San Francisco facilities, with the job cuts expected to be permanent.
The U.S. Food and Drug Administration issued a new template for clinical test developers that is designed to assist these companies in developing and submitting emergency use authorization (EUA) for Covid-19 tests that can be performed at home or in other settings besides laboratories.
Johnson & Johnson kicked off U.S. human safety trials for a Covid-19 vaccine after releasing details of a study in monkeys that showed the company’s best-performing vaccine candidate offered strong protection in a single dose.
EVERSAN and Havas Health & You announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and wellness clients worldwide.
British drugmaker AstraZeneca topped second-quarter sales and profit estimates and backed the company’s 2020 forecasts, helped by strong sales in lockdowns of a diverse product range that includes a potential coronavirus vaccine.